Shineco, Inc. (SISI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Shineco, Inc. (SISI) trades at $0.25 with AI Score 51/100 (Grade B). Shineco, Inc. is a healthcare company based in Beijing, China, focusing on the production of unique fabrics and health supplements derived from traditional Chinese medicinal plants. Market cap: $79,101, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for SISI: SISI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SISI against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SISI: 3/7 perspectives are bullish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Shineco, Inc. (SISI) Healthcare & Pipeline Overview
Shineco, Inc. specializes in the manufacturing of innovative fabrics and health supplements derived from Apocynum Venetum, positioning itself at the intersection of traditional Chinese medicine and modern healthcare solutions.
What Is the Investment Thesis for SISI?
Shineco, Inc. operates in a niche segment of the healthcare market, focusing on traditional Chinese medicine and health supplements. With a market cap of approximately $79,000 and a share price of $0.252, the company is currently facing substantial financial challenges, highlighted by a profit margin of -541.8% and a gross margin of 3.5%. However, the increasing consumer interest in health and wellness products, particularly those rooted in traditional practices, presents a potential growth catalyst. The company’s unique product offerings, derived from Apocynum Venetum, could tap into a broader market that values natural and holistic health solutions. As the market for health supplements in China continues to expand, Shineco's ability to innovate and adapt its product line will be critical for its recovery and growth. Investors should monitor the company's operational strategies and market positioning closely to assess future performance.
Based on FMP financials and quantitative analysis
SISI Key Highlights
- Market cap of approximately $79,000 indicates significant financial challenges.
- Profit margin of -541.8% reflects ongoing operational difficulties.
- Gross margin of 3.5% is below industry standards, signaling cost management issues.
- Beta of -1.89 suggests high volatility in stock performance.
- No dividend yield, indicating reinvestment in operations rather than shareholder returns.
Who Are SISI's Competitors?
SISI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NVS Novartis AG | $155.20 | -2.94% | $296.14B | 57 |
| AMGN Amgen Inc. | $365.01 | -2.44% | $197.00B | 83 |
| GILD Gilead Sciences, Inc. | $129.03 | -1.70% | $160.20B | 94 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SISI's Key Strengths?
- Unique product offerings that cater to a niche market.
- Established brand presence in traditional Chinese medicine.
- Ability to leverage traditional knowledge in modern applications.
What Are SISI's Weaknesses?
- Significant financial challenges with a low market cap.
- Negative profit margins indicating operational inefficiencies.
- High volatility in stock performance.
What Are the Key Risks for SISI?
- Financial-distress signal — its Altman Z-Score of -2.38 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-76.7%) — the business is not currently generating profit on shareholder capital.
What Are the Growth Opportunities for SISI?
- Expansion into Health Supplements Market: The health supplements market in China is projected to reach $30 billion by 2027, driven by increasing health awareness. Shineco can leverage its existing product lines to capture a share of this growing market, particularly by promoting the health benefits of Apocynum Venetum.
- Cultivation of Medicinal Plants: As the demand for natural health products rises, Shineco's involvement in cultivating medicinal plants provides a unique opportunity. The global market for herbal medicine is expected to grow at a CAGR of 8% through 2025, allowing Shineco to diversify its offerings and enhance its supply chain.
- Logistical Support Services: Shineco's logistics services for agricultural goods can be expanded to cater to other agricultural sectors. This could enhance revenue streams and capitalize on the growing demand for efficient supply chain solutions in the agricultural industry.
- Geographic Expansion: Shineco can explore opportunities to expand its market reach beyond China, targeting regions with growing interest in traditional medicine and health supplements. This could significantly increase its customer base and revenue potential.
- Partnerships with Health Institutions: Collaborating with healthcare providers and institutions to promote its health supplement products can enhance Shineco's credibility and market presence. Establishing partnerships could facilitate access to new customer segments and increase sales.
What Opportunities Does SISI Have?
- Growing demand for health supplements in China.
- Potential for geographic expansion into new markets.
- Increasing interest in natural and holistic health products.
What Threats Does SISI Face?
- Intense competition in the health supplement market.
- Regulatory challenges in the healthcare sector.
- Economic downturns affecting consumer spending on health products.
What Are SISI's Competitive Advantages?
- Unique product offerings derived from a traditional Chinese medicinal plant.
- Established presence in the growing health and wellness sector.
- Ability to blend traditional practices with modern scientific methods.
What Does SISI Do?
Founded in Beijing, China, Shineco, Inc. has established itself as a key player in the healthcare sector by focusing on the production and distribution of unique fabrics and health supplements. The company primarily derives its products from Apocynum Venetum, a plant native to China, which is known for its medicinal properties. Shineco’s offerings are not only limited to textiles but also include health-related products that aim to integrate traditional Eastern medicinal concepts with contemporary scientific methods. Over the years, Shineco has expanded its operations to include the cultivation of various trees such as yew and fast-growing bamboo willows, which are utilized for landscaping and other agricultural purposes. The company also provides logistical support services, enhancing its value proposition in the agricultural sector. Currently, Shineco operates within the People's Republic of China, leveraging the increasing demand for traditional Chinese medicine and health foods. Despite facing challenges such as a low market capitalization and significant operational risks, the company continues to strive for growth and innovation in its product offerings.
What Products and Services Does SISI Offer?
- Manufacture and supply unique fabrics and textiles derived from Apocynum Venetum.
- Produce health supplements that blend traditional Chinese medicine with modern science.
- Cultivate various trees for landscaping and agricultural purposes.
- Provide logistical support services for agricultural goods.
- Focus on the health and wellness sector in China.
How Does SISI Make Money?
- Revenue generated from the sale of textiles and health supplements.
- Income from the cultivation of medicinal and landscaping plants.
- Logistical support services as an additional revenue stream.
What Industry Does SISI Operate In?
The drug manufacturing industry, particularly in the specialty and generic segment, is experiencing robust growth driven by increasing consumer demand for health supplements and traditional medicine. The global market for herbal supplements is projected to grow significantly, with a compound annual growth rate (CAGR) of approximately 7% over the next five years. Shineco, Inc. operates within this expanding market, focusing on unique products that blend traditional Chinese medicine with modern health trends. The competitive landscape includes various players focusing on health supplements, but Shineco's niche in Apocynum Venetum products provides a distinct advantage in targeting specific consumer needs.
Who Are SISI's Key Customers?
- Health-conscious consumers seeking traditional Chinese medicine.
- Retailers and distributors of health supplements.
- Agricultural businesses requiring logistical support services.
Company Profile
Shineco, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Beijing, CN. The company is led by CEO Jennifer Zhan. SISI has traded publicly since 2016.
How Shineco, Inc. Is Valued
Shineco, Inc. carries a market capitalization of 79K, placing it in the micro-cap category. Relative to its peer group, SISI's quantitative score of 51/100 is below the peer average of 74/100.
ROE -77%Key Financial Metrics
Return on equity for Shineco, Inc. stands at -76.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -26.7%, showing how much profit it generates from its asset base. A current ratio of 0.76 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 5/9Financial Health
Shineco, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.38 places it in the distress zone, a signal of elevated financial risk.
Net buyingInsider Activity
The most recent 3 insider filings for Shineco, Inc. break down as 1 sales and 2 purchases. On net that is roughly 86K shares acquired (about $0) — insiders putting money in tends to read as conviction.
SISI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Unique product offerings that cater to a niche market.
- Established brand presence in traditional Chinese medicine.
- Ability to leverage traditional knowledge in modern applications.
Bear Case
- Significant financial challenges with a low market cap.
- Negative profit margins indicating operational inefficiencies.
- High volatility in stock performance.
- Intense competition in the health supplement market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SISI Latest News
No recent news available for SISI.
SISI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SISI.
Price Targets
Wall Street price target analysis for SISI.
SISI MoonshotScore
What does this score mean?
The MoonshotScore rates SISI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Common Questions About SISI (Healthcare)
What are the key factors to evaluate for SISI?
Shineco, Inc. (SISI) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does SISI data refresh on this page?
SISI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SISI's recent stock price performance?
Shineco, Inc. (SISI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique product offerings that cater to a niche market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SISI overvalued or undervalued right now?
Valuing Shineco, Inc. (SISI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SISI?
Before investing in Shineco, Inc. (SISI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SISI to a portfolio?
Key strength of Shineco, Inc. (SISI): Unique product offerings that cater to a niche market. Weigh rewards against risks and diversify. Not financial advice.
Can I buy fractional shares of SISI?
Yes, most major brokerages offer fractional shares of Shineco, Inc. (SISI) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track SISI's earnings and financial reports?
Shineco, Inc. (SISI) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for SISI earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.